108 related articles for article (PubMed ID: 9626476)
1. Differential permeability of a human brain tumor xenograft in the nude rat: impact of tumor size and method of administration on optimizing delivery of biologically diverse agents.
Neuwelt EA; Barnett PA; McCormick CI; Remsen LG; Kroll RA; Sexton G
Clin Cancer Res; 1998 Jun; 4(6):1549-55. PubMed ID: 9626476
[TBL] [Abstract][Full Text] [Related]
2. Improving drug delivery to intracerebral tumor and surrounding brain in a rodent model: a comparison of osmotic versus bradykinin modification of the blood-brain and/or blood-tumor barriers.
Kroll RA; Pagel MA; Muldoon LL; Roman-Goldstein S; Fiamengo SA; Neuwelt EA
Neurosurgery; 1998 Oct; 43(4):879-86; discussion 886-9. PubMed ID: 9766316
[TBL] [Abstract][Full Text] [Related]
3. Differential permeability and quantitative MR imaging of a human lung carcinoma brain xenograft in the nude rat.
Barnett PA; Roman-Goldstein S; Ramsey F; McCormick CI; Sexton G; Szumowski J; Neuwelt EA
Am J Pathol; 1995 Feb; 146(2):436-49. PubMed ID: 7856753
[TBL] [Abstract][Full Text] [Related]
4. Intra-arterial administration improves temozolomide delivery and efficacy in a model of intracerebral metastasis, but has unexpected brain toxicity.
Muldoon LL; Pagel MA; Netto JP; Neuwelt EA
J Neurooncol; 2016 Feb; 126(3):447-54. PubMed ID: 26694547
[TBL] [Abstract][Full Text] [Related]
5. The influence of anesthetic choice, PaCO2, and other factors on osmotic blood-brain barrier disruption in rats with brain tumor xenografts.
Remsen LG; Pagel MA; McCormick CI; Fiamengo SA; Sexton G; Neuwelt EA
Anesth Analg; 1999 Mar; 88(3):559-67. PubMed ID: 10072006
[TBL] [Abstract][Full Text] [Related]
6. Growth of human lung tumor in the brain of the nude rat as a model to evaluate antitumor agent delivery across the blood-brain barrier.
Neuwelt EA; Frenkel EP; D'Agostino AN; Carney DN; Minna JD; Barnett PA; McCormick CI
Cancer Res; 1985 Jun; 45(6):2827-33. PubMed ID: 2985254
[TBL] [Abstract][Full Text] [Related]
7. Decreased delivery and acute toxicity of cranial irradiation and chemotherapy given with osmotic blood-brain barrier disruption in a rodent model: the issue of sequence.
Remsen LG; McCormick CI; Sexton G; Pearse HD; Garcia R; Neuwelt EA
Clin Cancer Res; 1995 Jul; 1(7):731-9. PubMed ID: 9816039
[TBL] [Abstract][Full Text] [Related]
8. Enhanced delivery improves the efficacy of a tumor-specific doxorubicin immunoconjugate in a human brain tumor xenograft model.
Remsen LG; Trail PA; Hellström I; Hellström KE; Neuwelt EA
Neurosurgery; 2000 Mar; 46(3):704-9. PubMed ID: 10719867
[TBL] [Abstract][Full Text] [Related]
9. Imaging and therapy with rituximab anti-CD20 immunotherapy in an animal model of central nervous system lymphoma.
Muldoon LL; Lewin SJ; Dósa E; Kraemer DF; Pagel MA; Doolittle ND; Neuwelt EA
Clin Cancer Res; 2011 Apr; 17(8):2207-15. PubMed ID: 21385922
[TBL] [Abstract][Full Text] [Related]
10. The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.
Dahlborg SA; Petrillo A; Crossen JR; Roman-Goldstein S; Doolittle ND; Fuller KH; Neuwelt EA
Cancer J Sci Am; 1998; 4(2):110-24. PubMed ID: 9532413
[TBL] [Abstract][Full Text] [Related]
11. Differential permeability of the blood-tumour barrier in intracerebral tumour-bearing rats: antidrug antibody to achieve systemic drug rescue.
Kroll RA; Pagel MA; Langone JJ; Sexton GJ; Neuwelt EA
Ther Immunol; 1994 Dec; 1(6):333-41. PubMed ID: 7584509
[TBL] [Abstract][Full Text] [Related]
12. Unexpected neurotoxicity of etoposide phosphate administered in combination with other chemotherapeutic agents after blood-brain barrier modification to enhance delivery, using propofol for general anesthesia, in a rat model.
Fortin D; McCormick CI; Remsen LG; Nixon R; Neuwelt EA
Neurosurgery; 2000 Jul; 47(1):199-207. PubMed ID: 10917363
[TBL] [Abstract][Full Text] [Related]
13. Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide.
Nakano S; Matsukado K; Black KL
Cancer Res; 1996 Sep; 56(17):4027-31. PubMed ID: 8752174
[TBL] [Abstract][Full Text] [Related]
14. Alkylglycerol opening of the blood-brain barrier to small and large fluorescence markers in normal and C6 glioma-bearing rats and isolated rat brain capillaries.
Erdlenbruch B; Alipour M; Fricker G; Miller DS; Kugler W; Eibl H; Lakomek M
Br J Pharmacol; 2003 Dec; 140(7):1201-10. PubMed ID: 14597599
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of tumor cell exposure to [14C]methotrexate after intracarotid administration without and with hyperosmotic opening of the blood-brain and blood-tumor barriers in rat brain tumors: a quantitative autoradiographic study.
Shapiro WR; Voorhies RM; Hiesiger EM; Sher PB; Basler GA; Lipschutz LE
Cancer Res; 1988 Feb; 48(3):694-701. PubMed ID: 3335031
[TBL] [Abstract][Full Text] [Related]
16. Blood-brain barrier disruption and methotrexate in the treatment of a readily transplantable intracerebral osteogenic sarcoma of rats.
Cosolo W; Christophidis N
Cancer Res; 1987 Dec; 47(23):6225-8. PubMed ID: 3119195
[TBL] [Abstract][Full Text] [Related]
17. Effect of blood-brain barrier disruption on intact and fragmented monoclonal antibody localization in intracerebral lung carcinoma xenografts.
Neuwelt EA; Barnett PA; Hellström KE; Hellström I; McCormick CI; Ramsey FL
J Nucl Med; 1994 Nov; 35(11):1831-41. PubMed ID: 7965166
[TBL] [Abstract][Full Text] [Related]
18. Diphtheria toxin effects on brain-tumor xenografts. Implications for protein-based brain-tumor chemotherapy.
Wrobel CJ; Wright DC; Dedrick RL; Youle RJ
J Neurosurg; 1990 Jun; 72(6):946-50. PubMed ID: 2159988
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor blockade alters magnetic resonance imaging biomarkers of vascular function and decreases barrier permeability in a rat model of lung cancer brain metastasis.
Pishko GL; Muldoon LL; Pagel MA; Schwartz DL; Neuwelt EA
Fluids Barriers CNS; 2015 Feb; 12():5. PubMed ID: 25879723
[TBL] [Abstract][Full Text] [Related]
20. Delivery of herpesvirus and adenovirus to nude rat intracerebral tumors after osmotic blood-brain barrier disruption.
Nilaver G; Muldoon LL; Kroll RA; Pagel MA; Breakefield XO; Davidson BL; Neuwelt EA
Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9829-33. PubMed ID: 7568227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
